Notch Signaling and Efficacy PD-1/PD-L1 Blockade in Relapsed Small Cell Lung Cancer
Demographics (2)
- AGE - Subject age at study completion (phv00481722.v1.p1)
- SEX - Self-reported sex (phv00481716.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for Small Cell Lung Cancer (SCLC); all subjects are patients. (phv00481720.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00481721.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00481725.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00481724.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00481715.v1.p1)
- GENOTYPING_CENTER - Name of center which did genotyping (phv00481732.v2.p1)
- HISTOLOGICAL_TYPE - Tissue histology (phv00481727.v2.p1)
- IS_TUMOR - Tumor status (phv00481726.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Location of metastatic tumor (phv00481728.v2.p1)
- PRIMARY_TUMOR_LOCATION - Location of primary tumor (phv00481729.v2.p1)
- SAMPLE_ID - Sample ID (phv00481723.v2.p1)
- SAMPLE_ID - Sample ID (phv00481718.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00481733.v2.p1)
- SUBJECT_ID - Subject ID (phv00481719.v1.p1)
- SUBJECT_ID - Patient ID (phv00481714.v1.p1)
- SUBJECT_ID - Subject ID (phv00481717.v2.p1)
- TUMOR_STAGE - Stage of tumor (phv00481730.v2.p1)
- TUMOR_TREATMENT - Treatment given (phv00481731.v2.p1)